Prenatal Antidepressant Exposure and Childhood Autism Spectrum Disorders: Cause for Concern?

No abstract is available for this paper.

• Publication year

  2015

• Venue

  Pediatric Drugs

• Publication date

  2015-06-20

• Fields of study

  Medicine, Psychology

• Identifiers
  DOI 10.1007/s40272-015-0141-5PMID 26092083
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Title: Heritability of Autism Spectrum Disorder in a UK population-based twin sample.

  2016cited by this paper
• Heritability of Autism Spectrum Disorder in a UK Population-Based Twin Sample.

  2015cited by this paper
• Identification of natural direct effects when a confounder of the mediator is directly affected by exposure.

  2014cited by this paper
• Neural control of maternal and paternal behaviors

  2014cited by this paper
• Saving Lives, Improving Mothers' Care: Lessons learned to inform future maternity care from the UK and Ireland Confidential Enquiries into Maternal Deaths and Morbidity 2009-2012

  2014cited by this paper
• Prenatal antidepressant exposure is associated with risk for attention deficit-hyperactivity disorder but not autism spectrum disorder in a large health system

  2014influential reference
• Prenatal SSRI Use and Offspring With Autism Spectrum Disorder or Developmental Delay

  2014cited by this paper
• Prenatal exposure to selective serotonin reuptake inhibitors and autistic symptoms in young children: another red herring?

  2014cited by this paper
• Prenatal exposure to selective serotonin reuptake inhibitors and social responsiveness symptoms of autism: population-based study of young children

  2014influential reference
• In Utero Exposure to Selective Serotonin Reuptake Inhibitors and Risk for Autism Spectrum Disorder

  2014cited by this paper
• Prevalence of Antidepressant Use during Pregnancy in Denmark, a Nation-Wide Cohort Study

  2013cited by this paper
• Parental depression, maternal antidepressant use during pregnancy, and risk of autism spectrum disorders: population based case-control study

  2013cited by this paper
• Prenatal antidepressant exposure and behavioral problems in early childhood – a cohort study

  2013cited by this paper
• Antidepressant exposure in pregnancy and risk of autism spectrum disorders

  2013influential reference
• Use of selective serotonin reuptake inhibitors during pregnancy and risk of autism.

  2013cited by this paper
• From promises to practical strategies in epigenetic epidemiology

  2013cited by this paper
• Prenatal exposure to selective serotonin reuptake inhibitors and childhood overweight at 7 years of age.

  2013cited by this paper
• Prenatal valproate exposure and risk of autism spectrum disorders and childhood autism.

  2013cited by this paper
• Selective serotonin reuptake inhibitors and risk for major congenital anomalies.

  2012cited by this paper
• Sensitivity analysis for interactions under unmeasured confounding

  2012cited by this paper
• Selective Serotonin Reuptake Inhibitors and Risk for Major Congenital Anomalies

  2011cited by this paper
• Use of prescribed drugs among primiparous women: an 11-year population-based study in Denmark

  2011cited by this paper
• Antidepressant use during pregnancy and childhood autism spectrum disorders.

  2011cited by this paper
• Epidemiology, epigenetics and the 'Gloomy Prospect': embracing randomness in population health research and practice.

  2011cited by this paper
• Genetic heritability and shared environmental factors among twin pairs with autism.

  2011cited by this paper
• Investigating Outcomes Following the Use of Selective Serotonin Reuptake Inhibitors for Treating Depression in Pregnancy

  2011cited by this paper
• Length of prenatal exposure to selective serotonin reuptake inhibitor (SSRI) antidepressants: effects on neonatal adaptation and psychomotor development

  2011cited by this paper
• Serotonin and the autisms: a red flag or a red herring?

  2011cited by this paper
• Use of Acyclovir, Valacyclovir, and Famciclovir in the First Trimester of Pregnancy and the Risk of Birth Defects

  2011cited by this paper
• Fetal Exposure to Antidepressants and Normal Milestone Development at 6 and 19 Months of Age

  2010cited by this paper
• Prenatal Exposure to Maternal Depressed Mood and the MTHFR C677T Variant Affect SLC6A4 Methylation in Infants at Birth

  2010cited by this paper
• Use of acyclovir, valacyclovir, and famciclovir in the first trimester of pregnancy and the risk of birth defects.

  2010cited by this paper
• A review of fragile X premutation disorders: expanding the psychiatric perspective.

  2009cited by this paper
• Autism

  2009cited by this paper
• Selective serotonin reuptake inhibitors in pregnancy and congenital malformations: population based cohort study

  2009cited by this paper
• Epidemiology of Pervasive Developmental Disorders

  2009cited by this paper
• Sustained Neurobehavioral Effects of Exposure to SSRI Antidepressants During Development: Molecular to Clinical Evidence

  2009influential reference
• Prenatal exposure to maternal depression, neonatal methylation of human glucocorticoid receptor gene (NR3C1) and infant cortisol stress responses

  2008cited by this paper
• Inhibition of Serotonin But Not Norepinephrine Transport during Development Produces Delayed, Persistent Perturbations of Emotional Behaviors in Mice

  2008cited by this paper
• Use of antidepressant medications during pregnancy: a multisite study.

  2008cited by this paper
• Drug exposure side effects from mining pregnancy data

  2007cited by this paper
• Externalizing and attentional behaviors in children of depressed mothers treated with a selective serotonin reuptake inhibitor antidepressant during pregnancy.

  2007cited by this paper
• Use of selective serotonin-reuptake inhibitors in pregnancy and the risk of birth defects.

  2007cited by this paper
• First-trimester use of selective serotonin-reuptake inhibitors and the risk of birth defects.

  2007cited by this paper
• Internalizing behaviors in 4-year-old children exposed in utero to psychotropic medications.

  2006cited by this paper
• Neonatal Antidepressant Exposure has Lasting Effects on Behavior and Serotonin Circuitry

  2006cited by this paper
• Early-Life Blockade of the 5-HT Transporter Alters Emotional Behavior in Adult Mice

  2004cited by this paper
• Causal knowledge as a prerequisite for confounding evaluation: an application to birth defects epidemiology.

  2002cited by this paper
• Maternal stress induces synaptic loss and developmental disabilities of offspring

  1998cited by this paper
• Neurodevelopment of children exposed in utero to antidepressant drugs

  1997cited by this paper
• Maternal stress increases fetal brain and neonatal cerebral cortex 5-hydroxytryptamine synthesis in rats: a possible mechanism by which stress influences brain development.

  1990cited by this paper

• Studying the Contribution of Serotonin to Neurodevelopmental Disorders. Can This Fly?

  2021cites this paper
• Clinical Teratology

  2019cites this paper
• Antidepressant use in pregnancy: are we closer to consensus?

  2018cites this paper
• Maternal SSRIs experience and risk of ASD in offspring: a review.

  2018cites this paper
• Serotonin transporter immunoreactivity is modulated during development and after fluoxetine treatment in the rodent visual system.

  2017cites this paper
• Risk for Autism Spectrum Disorders According to Period of Prenatal Antidepressant Exposure: A Systematic Review and Meta-analysis

  2017cites this paper
• Risk for Autism SpectrumDisorders According to Period of Prenatal Antidepressant Exposure

  2017cites this paper
• The risks associated with prenatal antidepressant exposure: time for a precision medicine approach

  2017cites this paper
• Brain Fires in Autism Spectrum Disorders

  2016cites this paper
• Some options in studying side effects of drugs taken during pregnancy

  2015cites this paper